Todd Giorgio

Jennifer Herington, PhD, and Todd Giorgio, PhD, during their in-person visit to ARPA-H in July.
November 14, 2024

VUMC receives $3.3 million ARPA-H award to develop at-home therapy for preterm labor

This project will be the first to apply drug conjugates in the field of obstetrics.

By Danny Bonvissuto
August 16, 2022

Nanoparticles boost anti-cancer immunity

An ingenious targeted nanoparticle approach developed by Vanderbilt researchers reduced tumor burden in a model of ovarian cancer.

By Bill Snyder
April 8, 2015

Micelle “packets” deliver cancer drugs

Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells.

By VUMC News and Communications